HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore

March 15 -17, 2027 | Singapore

Primary CNS Lymphoma

Primary CNS Lymphoma

Primary CNS lymphoma (PCNSL) is a rare form of non-Hodgkin lymphoma that affects the central nervous system, including the brain, spinal cord, and eyes. Unlike other lymphomas, it primarily manifests within the brain, leading to symptoms such as headaches, cognitive dysfunction, and vision problems. Research on PCNSL focuses on understanding its unique biology and developing targeted therapies due to its limited response to traditional treatments like chemotherapy. Recent studies delve into the genetic mutations driving its growth and potential immunotherapies that harness the body's immune system to fight cancer cells specifically within the CNS. By unraveling the intricacies of PCNSL, researchers aim to improve diagnostic methods and devise more effective treatment strategies tailored to this challenging disease.

Committee Members
Speaker at International Cancer Research Conference - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at Cancer Science Conferences - Thomas Jay Webster

Thomas Jay Webster

Brown University, United States
Speaker at Oncology Conferences - Yan Leyfman

Yan Leyfman

NYP- Meyer Cancer Center, United States

Submit your abstract Today

Youtube
Watsapp